Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casopitant versus paroxetine versus placebo fMRI study in major depressive disorder
2006-001877-13Phase 2Terminated
- Sponsor
- GSK
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Casopitant, Paroxetine and Placebo (3 arms). Started Apr 2006; status: terminated.
02
Drugs
casopitantparoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2006-001877-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001877-13.